2021/08/27(金)
Pitch 2-2 :AlzMed, Inc. -New Strategy for Drug Discovery in Alzheimer's Disease-
【New Strategy for Drug Discovery in Alzheimer's Disease】
⇒The abstract is available in text.
Abstract of Alzmed.pdf
Profile
Dr. Shirao discovered drebrin, a protein that controls synaptic morphological changes in the brain, the basis of memory. In April last year, he founded AlzMed Inc., which is developing completely new diagnostic and therapeutic agents for Alzheimer's disease.